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Abstract
Background: Fatigue is a common symptom in Multiple Sclerosis (MS) and body cooling may be an important
non-pharmacological treatment strategy for fatigue by, for instance, reducing the loss of axonal conduction efficiency
due to Uhthoff’s phenomenon. However, up to now, no studies have demonstrated such a treatment effect for
mentally induced fatigue.
Methods: In this single-blinded randomized placebo controlled cross-over design we studied the effects of
cooling on cognitive fatigue and autonomic functioning (heart rate variability and sympathovagal balance measures)
during a vigilance task in 31 MS patients and 10 controls.
Results: Task performance, fatigue and sympathovagal balance did not differ between verum- and placebo
condition after controlling for depressive mood. MS patients showed more omissions on the vigilance test than
controls; their performance declined during the task and this correlated significantly with cognitive fatigue. Cardiac
sympathetic drive remained unchanged during vigilance testing in MS patients, but it increased significantly in
controls.
Conclusion: Cooling has no impact on experienced cognitive fatigue and on cognitive performance in MS
patients. Vigilance testing seems to be an appropriate behavioural measure of cognitive fatigue. Cardiac
sympathetic drive to compensate for mental strain is reduced in MS patients, indicating an autonomic dysfunction.
Keywords: Multiple sclerosis; Fatigue; Autonomic functioning;
Heart rate variability; Vigilance; Effects of cooling
Introduction
Fatigue is a common symptom in Multiple Sclerosis (MS) [1].
Patients often report cognitive deficits in association with fatigue, but
a clear connection between subjectively experienced cognitive
limitations and objective performance on specific neuropsychological
tests has not been demonstrated convincingly [2]. Moreover, the
influence of fatigue on cognition has been assessed with subjective
measures only in most studies. Hence, finding an adequate objective
measure for fatigue is one of the aims of the present study.
Several explanations have been suggested for fatigue in MS [3].
Most studies focused on supratentorial lesions or demyelination, but
dysfunctions of the autonomic nervous system, have also been
mentioned [4]. Autonomic dysfunctions like sleep disorders [5], loss
of bladder control [6], depressive mood [7] and orthostatic
hypotension are common in MS [8], statistically associated with
fatigue [9]. A recent review argues for a direct link between
hypothalamic lesions and fatigue in neurological diseases [10].
Presumably, a decrease of top-down control, due to demyelinated
structures of the autonomic nervous system, results in a loss of bodily
adaptation (i.e., changes in heart rate, blood pressure, distribution of
cortisol and adrenaline) in reaction to mental and physical stress and
thus to fatigue.
Demyelination of nerve fibres related to the motor system may play
a direct role in increased fatigability of MS patients [3,10]. Uhthoff
[11] was the first to observe an impaired acuity of MS patients after
motor exhaustion. Later-on, exaggeration of neurological impairments
was noticed in MS patients during fever, after taking a hot bath or
visiting a sauna and it was termed the Uhthoff phenomenon [12,13].
The explanation for this exaggeration of symptoms is a relative loss of
axonal conduction capacity in de- or incompletely remyelinated nerve
fibres in response to heating of the body tissue.
Heat sensitivity is a common symptom in MS [14] and appears to
be associated with fatigue [15] and cognitive performance [13].
Actually, increased sensitivity to heat may be a consequence of a loss
of top-down autonomic nervous system control, as peripheral
sudomotor activity and sweat gland innervations are controlled by
brain stem areas and thermoregulation is under hypothalamic control.
Reduced sweating and abnormal sympathetic skin responses have been
reported in MS patients [14].
Given this relation between heat, conduction capacity of nerve
fibres and fatigue, external cooling has been investigated as a
treatment strategy. While there is some proof of amelioration of visual
and motor symptoms [16,17], to our knowledge no study examined
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the effect of cooling on performance and cognitive fatigue in mentally
challenging tasks. We investigated the effect of a cooling vest in MS
patients in a placebo controlled cross-over design. We used a vigilance
test from the Test Battery for Attentional Performance (TAP) [18] for
the following reasons. An older review showed that only performance
in prolonged sustained attention tasks correlates with fatigue, [2] and a
recent review on the cognitive signature of fatigue argues that vigilance
and alertness are the only more experimental cognitive tasks that
reliably correlate with fatigue in MS [20]. Alertness and vigilance rely
on similar cognitive functions and neuroanatomical structures, [19]
the latter being modulated by brain stem nuclei responsible for the
release of noradrenaline and histamine, two neurotransmitter directly
related to sleep-wake regulation. But only the vigilance task seems to
induce cognitive fatigability directly correlated with experience of
fatigue in MS patients, possibly due to its longer duration [2,20].
Moreover, vigilance performance correlates with heart rate variability
(HRV) [21] and HRV seems to be a sensitive measure for autonomic
nervous system activity and fatigue, as shown in cancer patients [22].
Neuroanatomical structures associated with vigilance are the locus
coeruleus, the brain stem arousal system and right hemispheric frontal
and parietal areas [23]. MS patients with fatigue show atrophy
particularly in the right parietal and frontal cortex [24] and a vigilance
decrement therefore can be expected.
This study aimed to examine whether fatigue is related to vigilance
decrement and to reactivity of the autonomic nervous system, as
measured by HRV, and whether a cooling vest reduces the increase of
fatigue and of performance decline during such a cognitive task.
Methods
Subjects
Thirty-one patients with relapsing-remitting MS as defined by the
McDonald criteria [25] and 10 controls participated (for demographic





Gender f=26, m=5 f=6, m=4
Age 42.5 ± 11.4 42.8 ± 10.6
Disease duration 124.7 ± 110.2 -
EDSS 3.6 ± 2.1 -
FSMC 72.8 ± 17.5 37.5 ± 15.5
BDI 12.3 ± 8.1 3.8 ± 4.0
BDI-psy 7.8 ± 6.2 2.2 ± 2.6
BDI-som 5.2 ± 4.1 1.7 ± 1.5
SD: Standard Deviation; EDSS: Expanded Kurtzke Disability Status Scale;
FSMC: Fatigue Scale for Motor and Cognitive Functions; BDI: Beck‘s
Depression Inventory; psy: psychological component; som: somatic component
Table 1: Demographical and clinical characteristics of the groups.
All patients were relapse- and corticosteroid-free for at least six
weeks prior to the study and without any psychiatric disorders or
significant medical conditions (for example cardio-vascular
dysfunctions, treatment with psychostimulants) that could confound
the study. Patients were recruited by postings and circular letters
inviting to participate in a study on cooling and fatigue. Healthy
controls were selected mainly of the group of hospital’s employees,
trying to match for age, gender and education. The Expanded
Disability Status Scale (EDSS) [26] served as a measure of disability.
Approval was obtained from the Bremen Physicians Ethics
Committee. All participants gave informed consent.
Procedure
Room temperature was held constant between 21 and 22 degrees
Celsius, the normal house room temperature and participants adapted
to this temperature during the first 25 minutes.
The cooling vest [27] was then prepared with 3 litres of cold water
at 13°C for the verum condition, or 1 litre at 27°C for the placebo-
condition. The two conditions were presented in a counterbalanced
order. Participants wore two thin cotton shirts during verum and 3
shirts plus an extra towel placed invisibly at the back during placebo
condition. In both conditions the vest was worn for 40 minutes during
vigilance testing with simultaneous collection of heart rate data and
the fatigue assessment (visual analogue scale). There was a 20 minute
break between conditions for re-adaptation to the room temperature.
We used a single-blind placebo controlled study design. Blinding of
the patients was guaranteed by telling them that the main goal of the
study is to find out the optimal cooling temperature for the vest,
indicating that both cooling temperatures will work. The investigator
was not blind for the conditions, but was unable to interfere with the
PC based evaluation of the outcome measures.
Assessments
Body temperature was measured in-ear and on the patient’s
shoulder three times: at the beginning of the investigation as a baseline
value and once after each cooling condition.
Vigilance testing was done for 30 minutes. The acoustic version was
used because of possible visual impairments due to previous optic
neuritis. Participants were instructed to listen to alternating beeps of
440 and 1000 Hz, presented with an inter-stimulus interval of 1.3 sec.
Occasionally, two beeps of the same frequency were presented in a row
and the participants had to press a button as quickly as possible. There
were 36 targets out of 1200 beeps over the whole test of 30 minutes.
The interval between critical targets varied between 40 and 60 seconds.
Omissions of target stimuli were calculated and time-on-task effects
were determined by comparing omissions for the first 15 minutes and
second 15 minutes. Before testing, participants practiced for 3 minutes
to adapt to the beeps and the target sequence. We focused on
omissions as they offer the most relevant information about drop of
performance.
Participants were asked to rate their current feeling of fatigue on a
100 mm Visual Analog Scale (VAS, 0=no fatigue at all, 100=fully
fatigued) at baseline and once during each cooling condition.
Heart rate as indication of autonomic nervous system activity was
assessed during both cooling conditions, using the device “parport”
from Par-Elektronik [28].
Electrodes were placed in standard positions under both clavicles
and on the left side of the stomach. HR was assessed using the R-spike
interval as the R-spike signal is easily detectable due to the high
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amplitude and the high flank steepness. Amplitude maximum was
determined by a Schmitt-Trigger. The signal was standardized by a
maximum detection which controlled a variable amplifier. The
common mode rejection was performed by an initial high pass with
0.5-Hz cut-off frequency. The P- and T-waves, which have a lower
frequency spectrum than the R-spike, were rejected by a band pass
with cut-off frequencies of 20 and 30 Hz. In addition, an R-spike
interval lower than 240 ms was prevented by a monostable
multivibrator. So the maximum HR could be 250 min–1. Heart rate
was converted by Fast Fourier Transformation (FFT) and a time-
dependent spectral analysis was performed. According to the
consensus statement on HRV analysis (1996), [29] band width was
defined as between 0.012 Hz to 0.043 Hz for the very low-frequency
band, 0.047 Hz to 0.152 Hz for the low-frequency band and 0.156 Hz
to 0.402 Hz for the high-frequency band. After log transformation of
these data, we calculated the ratio of very low frequency to high
frequency (VLF/HF) and the ratio of low frequency to high frequency
(LF/HF) as estimates of sympathetic activity and sympathovagal
balance.
The beginning and end of the vigilance test was marked
electronically. Physiological data were inspected for technical artifacts
and time-on-task effects were analyzed by averaging the results of the
first and second 15 minutes period.
Additionally, participants completed the Fatigue Scale for Motor
and Cognitive Functions (FSMC) [30]. According to the manual of the
FSMC the cut-off score of 43 was used to divide the MS patients in
those with and without fatigue. We also presented the Beck‘s
Depression Inventory (BDI) [31] and determined the psychological
component and the somatic component of depressive mood separately
by adding items A-L for the first and M-U for the latter aspect. The
somatic items also concern sleepiness and sleep impairments. Hence,
we focused on the psychological items to correct for depressive mood
in the statistical evaluations.
Statistical evaluation
Repeated measures analyses of variance (ANCOVA) were used to
analyse performance on the vigilance task. To control for a potential
effect of depressive symptoms on fatigue, the score on the
psychological component of BDI was used as a covariate in all
analyses.
Verum versus Placebo was defined as the within-group factor
Treatment. Time-on-task effects were defined as the within-group
factor Time (first half against second half of the 30 minutes period of
vigilance testing). The between subjects factor was defined as Group
(patients vs controls). Significant interactions between Group and
Treatment and Group and Time were further analysed by t-tests for
dependent measurements.
We first compared the whole MS group with the healthy controls
and subsequently repeated the analysis excluding MS patients without
fatigue (n=3).
Results
Effect of cooling on body temperature
Cooling led to a highly significant difference between the Verum
and Placebo condition (main effect Treatment [F (1,38): 88.696,
p<0.001], a main effect of Place (skin versus ear)
[F (1,38): 34.870, p<0.001)], but there was no main effect of Group and
there were no significant interaction effects. Decline of temperature
was much higher when measured at the shoulder than in the ear
(Table 2). Excluding MS patients without fatigue the ANCOVA
produced similar statistical results.
Initial measurement Verum Placebo
MS Controls MS Controls MS Controls
Visual analogue scale (Fatigue) 29.2 ± 22.3 29.4 ± 25.8 40.7 ± 26.7 * 42.6 ± 25.1 51.3 ± 28.1 *,# 48.1 ± 19.7
Temperature Ear
Skin
37.0 ± 0.4 36.8 ± 0.4 36.9 ± 0.4 * 36.8 ± 0.4 * 36.9 ± 0.4 * 36.8 ± 0.5
34.5 ± 1.4 34.6 ± 1.1 32.0 ± 1.8 * 32.1 ± 2.6 * 33.7 ± 1.8 *,# 34.0 ± 2.1 *,#
Heart rate (variance) 2.5 ± 1.0 2.5 ± 1.0 2.5 ± 0.5 2.6 ± 0.7
ms: milliseconds; Mean ± Standard deviation
*p<0.05 compared to initial measurement, #p<0.05 compared to verum-condition
Table 2: Effects of external cooling.
Fatigue
Three MS patients showed no fatigue according to the cut-off score
of the MSFC. MS patients with fatigue scored significantly higher on
FSMC than controls (p<0.001). Also, the psychological component of
the BDI was significantly higher among MS patients (p=0.004). The
two groups did not differ in age, education and gender.
The application of cooling (Treatment) had no significant impact
on fatigue [F (1,38): 3.178, p=0.054] as measured with the visual
analogue scale, but there was a significant Group difference [F (1,38):
6.820, p=0.003]. The interaction between Group and Treatment was
not significant. Patients without cognitive fatigue showed the lowest
fatigue score, patients with fatigue the highest and healthy controls
scored in between these two groups.
T-tests for dependent measures for MS patients, not controlling for
depressive mood, showed significant differences between cognitive
fatigue scores before and after vigilance testing in the Verum
condition, and there was also a significant difference between verum
and placebo condition. No difference between verum and placebo was
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found for the healthy controls, and this might be due to the small
number of participants (Table 2).
Hence, fatigue increased during the vigilance task in both groups
(significant dependent t-tests), which was performed just before the
fatigue measurement in the Placebo and the Verum condition. Fatigue
was also higher for MS patients in the Verum than in the Placebo
condition, but this effect disappeared when we controlled for
depressive mood (no significant interaction effect between Group and
Treatment in the ANCOVA).
Vigilance
The ANCOVA of the vigilance task revealed a main effect of Time
[F (1,38): 6.102, p=0.018], a main effect of Group [F (1,38): 5.801,
p=0.021], and a significant interaction between Time and Group [F
(1,38): 6.096, p=0.018]. There was no main effect of Treatment or a
significant interaction between Treatment and any of the other factors.
Excluding MS patients without fatigue we found a main effect of
Time [F (1,35): 8.460, p=0.006], a main effect of Group [F (1,35):
8.555, p=0.006], and a significant interaction between Time and Group
[F (1,35): 8.296, p=0.007]. MS Patients with fatigue made more
omissions than healthy controls irrespective of cooling condition.
Moreover, patient’s performance declined significantly during the task
(Table 2), while healthy controls improved slightly (Figure 1).
Therefore, the application of active temperature cooling (verum
condition) did not improve performance of MS patients in
comparison to that of healthy controls, but MS patients performed
worse in the vigilance test and were more sensitive to time-on-task in
the vigilance test.
Figure 1: Omissions in vigilance testing.
Error bars: standard error of mean; *p<0.05 for independent t-test.
To check whether there was a pure sequence between the
conditions (for instance, a decrement of performance in condition two
because having already performed condition one), we rearranged our
data and did the same statistical analyses as mentioned above. Because
the sequence factor did not yield any significant results, we can
exclude such an influence on our data.
HRV analysis
Data from 5 participants showed technical artifacts during one of
the measurements and were excluded from the analysis.
Comparing the whole group of MS patients with healthy controls
on the LF/HF ratio, there was no main effect of Treatment, Time and
Group, but there was a significant interaction between Time and
Group [F (1,33): 5.095, p=0.031], showing a small decrease of LF/HF
in MS patients while the scores of controls increased over time.
Comparing only MS patients with fatigue to healthy controls, there
was no main effect of Treatment, Time or Group, but there was a
significant interaction between Time and Group [F (1,30): 4.599,
p=0.04]. Dependent t-tests did not reveal significant differences.
Comparing the whole group of MS patients with healthy controls,
the ANCOVA on the VLF/HF ratio showed no main effect of
Treatment, Time and Group, and no significant interactions. The
main effect of Group approached significance (p=0.076) (Figure 3).
Comparing only MS patients with fatigue to healthy controls did
not change these results.
Hence, vigilance testing and not cooling affected heart rate
variability differentially in MS patients and healthy controls.
Post-hoc correlational analyses (only for MS patients)
The EDSS scores did not correlate with performance on the
vigilance tasks (split up for the first and second half of the task) and
the VAS scores. Therefore, our results cannot simply be explained by
the degree of disability.
Fatigue as measured with a visual analogue scale, before and after
each vigilance task, correlated with the number of omissions made in
the second half of the vigilance test, even when controlling for the sum
score of psychological items of the BDI (Table 3), but it did not
correlate with HRV.
Discussion
External cooling did not result in a subjective or objective
amelioration of fatigue that differed from that in the placebo
condition, but we found a fatigue-related performance decline on a
vigilance test and a reduced reaction in cardiac sympathetic drive in
response to vigilance testing in MS patients compared to healthy
controls.
Wearing a cooling vest neither led to a reduction of fatigue (at least
not after controlling for depressive mood) nor did it improve
performance on the vigilance task. This deviates from findings of some
previous studies [32-35]. Several aspects have to be mentioned, which
might explain our negative results. First of all, none of these previous
studies controlled statistically for the effect of depressive mood.
Actually, without such a control our patients would have experienced
significantly less fatigue in the verum condition compared to the
placebo condition, which was our original expectation (Table 2).
Secondly, we focused on cognitive fatigue and cognitive performance.
The only study we are aware of that measured cognitive performance
in MS patients with fatigue (but not specifically cognitive fatigue)
before and after cooling revealed – as our study did - no improvement
in cognition, but in motor efficiency [36]. Motor efficiency, measured
by timed up and go test and timed walking tests, was often used to
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measure improvement after cooling [37,38]. Therefore, one
explanation could be that cooling affects motor performance.
Accordingly, non-motor functions like visual acuity, which also has
been assessed in previous studies, did not response to cooling [36,39].
Verum, 1st half Verum, 2nd half Placebo, 1st half Placebo, 2nd half
MS Controls p MS Controls p MS Control p MS Control p
Vigilance
(omissions)
1.7 ± 2.3 0.4 ± 0.5 0.007 2.4 ± 2.3 0.1 ± 0.3 0.000 1.3 ± 1.7 0.6 ± 0.7 0.067 3.2 ± 3.9 0.9 ± 1.3 0.007
LF/HF 0.8 ± 0.3 1.0 ± 0.3 0.188 0.8 ± 0.4 1.1 ± 0.2 0.049 0.9 ± 0.3 1.0 ± 0.2 0.353 0.9 ± 0.3 1.0 ± 0.2 0.107
VLF/HF 1.0 ± 0.4 1.2 ± 0.5 0.261 0.9 ± 0.5 1.3 ± 0.3 0.044 1.0 ± 0.4 1.2 ± 0.2 0.080 1.0 ± 0.4 1.2 ± 0.3 0.200
p: Significance level for independent testing; LF/HF: ratio low frequency/ high frequency components; VLF/HF: very low frequency/ high frequency components, Mean
± Standard deviation
Table 3: Effects of external cooling.
Second, most of the studies examined only heat sensitive patients
with fatigue; heat sensitivity was not an inclusion criterion in our
study [39,40]. Heat sensitivity is one aspect of fatigue, but is not
experienced by all MS patients with fatigue. Perhaps, only heat
sensitive MS patients profit from cooling. Sumowski and Leavitt found
that body temperature is closely related to motor fatigue but not to
cognitive fatigue [41].
Third, differences in the effects of cooling procedures among
studies may also play a role. Inner ear temperature declined only
marginally in our MS patients group (0.1°C). Previous studies reported
declines of inner ear temperature of 0.3°C to 0.4°C, but this was not
the case for all studies [42]. These differences between the studies are
remarkable and not easy to explain. We used a cooling vest, a cooling
temperature far below the value that is proposed by the manufacturer
and a cooling period of 30 minutes. This is similar to procedures from
previous studies, and many of the MS patients indicated to suffer from
wearing the vest with such a low temperature. The subjectively
experienced cooling was so intense that a more rigorous cooling would
exclude any clinical application. Last but not least, our cooling resulted
in a significant difference between placebo- and verum-condition, and
skin temperature decreased after verum cooling about 2.5°C in MS
patients and only 0.7°C after placebo cooling (compared to skin
temperature before cooling).
Hence, cooling may be effective for motor, but not for cognitive
fatigue, because exhausting motor performance leads to increase of
body heat and demyelinated nerve fibres then lose their ability of
efficient conduction relative to tissue temperature (the Uhthoff
phenomenon) [13], a mechanism that is irrelevant during cognitive
processing. On the other hand, we cannot exclude that more effective
cooling, as in our study, may lead to improvement in cognitive tasks,
too.
Vigilance testing clearly induced objective fatigue, i.e. the typical
vigilance decrement [19] in MS patients (Figure 1). Moreover,
compared to the healthy control participients subjects, sympathetic
heart rate modulation did not increase (Figure 2 and 3).
Figure 2: Sympathovagal balance (LF/HF).
Figure 3: Sympathovagal balance (VLF/HF).
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In his excellent review DeLuca [2] distinguished between cognitive
fatigue induction by extended periods of mental or motor testing or by
sustained attention tasks. Simply challenging patients with tasks over
an extended period of time did not produce task related impairments.
On the other hand, studies using sustained attention tasks did find a
decrease in performance. For instance, performance on an alertness
task, but not on memory tests, correlates with fatigue [20].
Unfortunately, the alertness task shows a decrease of objective
performance in MS patients only after an extended period of
exhaustion. Moreover, it does not correlate with the increase of fatigue
during that performance [20]. In our investigation differences between
patients and controls became evident on the vigilance task already
after 15 minutes, and performance decline correlated with experienced
cognitive fatigue (Table 3). Therefore the vigilance test appears to be a
well-suited measure for cognitive fatigue.
As a biological marker of increased fatigability we also found a HRV
dysregulation in MS patients performing the vigilance task (Figure 2
and Figure 3). This is in line with other studies demonstrating a role of
the autonomic nervous system in the development of fatigue in
reaction to mental strain [34] or to postural changes [33]. The
difference between patients and controls was more evident for the
LF/HF than for the VLF/HF ratio. Although both measures are
considered to be indicators of sympathovagal balance, the assessment
of VLF/HF is not recommended for short-term recordings in the
consensus statement of 1996 [29] as the physiological interpretation of
this component is not clear. This might explain the restricted effect of
the vigilance task on this latter ratio. The reduced sympathetic-
autonomic response to cognitive load in MS patients supports the
hypothesis of a lack of cortical top-down control due to either
demyelinization of fibres in the brain stem or damage to subcortical
(hypothalamic) areas. However, the LF/HF and VLF/HF scores did
neither correlate with test performance nor with fatigue. Therefore,
future studies have to show whether and how HRV dysregulation and
increased feeling of fatigue may be related.
Our study has some limitations. First, to ensure blinding we
decided that some degree of cooling was necessary in the placebo
condition, which may have had a minor effect on the results.
Furthermore, including more MS patients without fatigue would have
been helpful in order to distinguish between fatigue and other MS-
related symptoms. A strong point was that we assessed cognitive
performance, experienced cognitive fatigue and physiological
parameters of fatigue. Moreover, potential influences of depressive
mood on vigilance were statistically controlled for. As a clinically
relevant finding, our data indicate that fatigue should be assessed by
looking for vigilance decrements. Moreover, autonomic dysfunctions
may be more common in MS patients if heart rate variability is
measured under conditions of sustained attention over periods longer
than thirty minutes. On the other hand, according to our data, cooling
is ineffective in ameliorating subjectively and objectively measured
cognitive fatigue.
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